ECO Animal Health Group (LON:EAH) Sets New 52-Week Low – Should You Sell?

ECO Animal Health Group plc (LON:EAH) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 66 ($0.86) and last traded at GBX 67 ($0.87), with a volume of 168382 shares changing hands. The stock had previously closed at GBX 73.50 ($0.95).

Analyst Ratings Changes

Separately, Shore Capital reiterated a “buy” rating on shares of ECO Animal Health Group in a research note on Tuesday, August 27th.

ECO Animal Health Group Price Performance

The company has a market cap of £45.39 million, a PE ratio of 3,675.00 and a beta of -0.05. The company has a debt-to-equity ratio of 4.31, a current ratio of 2.96 and a quick ratio of 2.14. The stock’s 50-day moving average is GBX 96.85 and its 200 day moving average is GBX 108.13.

Insider Transactions at ECO Animal Health Group

In other ECO Animal Health Group news, insider David Hallas purchased 18,181 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was bought at an average cost of GBX 110 ($1.43) per share, for a total transaction of £19,999.10 ($25,966.11). Insiders own 21.65% of the company’s stock.

ECO Animal Health Group Company Profile

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.